LETTER
COMPLEMENT
COMPONENTS
IN
CYSTIC
FIBROSIS
DR
CONOVER
AND
HIS
COLLEAGUES
REPORTED
NO
DIFFERENCE
IN
THE
HAEMOLYTIC
ACTIVITY
OF
SERUM
COMPLEMENT
COMPONENTS
C1C9
OF
CYSTIC
FIBROSIS
CF
PATIENTS
OBLIGATE
HETEROZYGOTES
AND
NORMAL
CONTROLS
THEY
ALSO
MEASURED
INDIVIDUAL
COMPLEMENT
COMPONENTS
BY
RADIAL
IMMUNODIFFUSION
AND
FOUND
A
SIGNIFICANT
RISE
OF
C3
BUT
NO
SIGNIFICANT
DIFFERENCE
IN
C5
LEVELS
BETWEEN
THESE
GROUPS
USING
IMMUNODIFFUSION
KITS
FROM
THE
SAME
MANUFACTURER
AND
FRESHLY
OBTAINED
SERA
WE
HAVE
OBSERVED
QUITE
DIFFERENT
FINDINGS
C5
WAS
MILDLY
ELEVATED
IN
20
AND
MORE
HIGHLY
ELEVATED
IN
25
OF
56
CF
PATIENTS
2
TO
29
YEARS
OF
AGE
C5
WAS
ALSO
ELEVATED
IN
24
OF
51
PARENTS
OF
CF
PATIENTS
15
SHOWING
MILD
AND
9
HIGHER
ELEVATIONS
WHILE
4
OF
24
CONTROLS
SHOWED
ONLY
MILD
ELEVATION
NO
CORRELATION
WAS
OBSERVED
BETWEEN
SERUMC5
LEVELS
AND
THE
AGE
SEX
CLINICAL
SEVERITY
OF
DISEASE
JUDGED
BY
SHWACHMANKULCZYKI
SCORES
SPUTUM
BACTERIAL
COLONISATION
AND
MODE
OF
TREATMENT
OF
THE
CF
PATIENTS
THE
ELEVATION
OF
C3
AND
C5
IN
A
MAJORITY
OF
PATIENTS
WITH
CF
AND
OBLIGATE
HETEROZYGOTES
IS
VERY
INTERESTING
AND
IS
SUGGESTIVE
OF
CERTAIN
GENETIC
DEFECTS
IN
THE
COMPLEMENT
ACTIVATION
SYSTEM
IN
THIS
AUTOSOMAL
RECESSIVE
DISORDER
